Vertex Pharmaceuticals (VRTX) Gross Margin (2010 - 2026)
Vertex Pharmaceuticals' quarterly Gross Margin came in at 86.85% in Q1 2026, down 5.0% year-on-year from 91.42% in Q1 2025, and up 1.71% quarter-over-quarter from 85.39% in Q4 2025.
Vertex Pharmaceuticals has reported Gross Margin for 17 years, with the latest figure at 86.85% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 5.0% year-over-year to 86.85%; the trailing twelve-month figure through Mar 2026 stood at 86.24% (up 21.0% YoY), and the FY2025 full-year result was 86.24%, up 13.0% from the prior year.
- Gross Margin for Q1 2026 stood at 86.85%, up from 85.39% in the prior quarter.
- The five-year high for Gross Margin was 88.76% in Q1 2023, with the low at 85.38% in Q4 2023.
- Average Gross Margin over 5 years is 86.88%, with a median of 86.9% recorded in 2025.
- Year-over-year, Gross Margin soared 79 bps in 2022 and tumbled 231 bps in 2023.
- Tracing VRTX's Gross Margin over 5 years: stood at 87.7% in 2022, then decreased by 3 bps to 85.38% in 2023, then rose by 0 bps to 85.46% in 2024, then fell by 0 bps to 85.39% in 2025, then gained by 2 bps to 86.85% in 2026.
- The last three Gross Margin figures came in at 86.85% (Q1 2026), 85.39% (Q4 2025), and 86.52% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 82.22% |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.85% |
| Dec 31, 2025 | 85.39% |
| Sep 30, 2025 | 86.52% |
| Jun 30, 2025 | 86.25% |
| Mar 31, 2025 | 86.90% |
| Dec 31, 2024 | 85.46% |
| Sep 30, 2024 | 85.84% |
| Jun 30, 2024 | 85.94% |
| Mar 31, 2024 | 87.27% |
| Dec 31, 2023 | 85.38% |
| Sep 30, 2023 | 87.17% |
| Jun 30, 2023 | 87.62% |
| Mar 31, 2023 | 88.76% |
| Dec 31, 2022 | 87.70% |
| Sep 30, 2022 | 87.60% |
| Jun 30, 2022 | 88.08% |
| Mar 31, 2022 | 88.28% |
| Dec 31, 2021 | 88.06% |
| Sep 30, 2021 | 88.08% |
| Jun 30, 2021 | 87.29% |
| Mar 31, 2021 | 88.85% |
| Dec 31, 2020 | 87.52% |
| Sep 30, 2020 | 87.90% |
| Jun 30, 2020 | 87.90% |
| Mar 31, 2020 | 89.27% |
| Dec 31, 2019 | -18.75% |
| Sep 30, 2019 | 86.11% |
| Jun 30, 2019 | 85.58% |
| Mar 31, 2019 | 88.92% |
| Dec 31, 2018 | 85.95% |
| Sep 30, 2018 | 85.82% |
| Jun 30, 2018 | 86.12% |
| Mar 31, 2018 | 88.82% |
| Dec 31, 2017 | 87.10% |
| Sep 30, 2017 | 87.40% |
| Jun 30, 2017 | 86.91% |
| Mar 31, 2017 | 93.43% |
| Dec 31, 2016 | 87.00% |
| Sep 30, 2016 | 87.01% |
| Jun 30, 2016 | 89.63% |
| Mar 31, 2016 | 87.49% |
| Dec 31, 2015 | 84.73% |
| Sep 30, 2015 | 89.99% |
| Jun 30, 2015 | 90.72% |
| Mar 31, 2015 | 92.83% |
| Dec 31, 2014 | 92.19% |
| Sep 30, 2014 | 92.55% |
| Jun 30, 2014 | 92.11% |
| Mar 31, 2014 | 92.76% |
| Dec 31, 2013 | 89.69% |
| Sep 30, 2013 | 90.96% |
| Jun 30, 2013 | 90.31% |
| Mar 31, 2013 | 90.57% |
| Dec 31, 2012 | 77.37% |
| Sep 30, 2012 | 90.87% |
| Jun 30, 2012 | 75.01% |
| Mar 31, 2012 | 93.10% |
| Dec 31, 2011 | 95.93% |
| Sep 30, 2011 | 91.59% |
| Mar 31, 2011 | 100.00% |
| Jun 30, 2010 | 100.00% |